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Most indigenous ethnias from Northern Argentina live in rural areas of “the Gran 
Chaco” region, whereTrypanosoma cruzi is endemic. Serological and parasitological 
features have been poorly characterised in Aboriginal populations and scarce 
information exist regarding relevant T. cruzi discrete typing units (DTU) and parasitic 
loads. This study was focused to characterise T. cruzi infection in Qom, Mocoit, 
Pit´laxá and Wichi ethnias (N=604) and Creole communities (N=257) inhabiting rural 
villages from two highly endemic provinces of the Argentinean Gran Chaco. 
DNA extracted using Hexadecyltrimethyl Ammonium Bromide reagent from 
peripheral blood samples was used for conventional PCR targeted to parasite 
kinetoplastid DNA (kDNA) and identification of DTUs using nuclear genomic markers. 
In kDNA-PCR positive samples from three rural Aboriginal communities of “Monte 
Impenetrable”, minicircle signatures were characterized by Low stringency single 
primer–PCR and parasitic loads calculated using  Real-Time PCR. 
Seroprevalence was higher in Aboriginal (47.98%) than in Creole (27.23%) rural 
communities (Chi square, p= 4.e-8). A low seroprevalence (4.3%) was detected in a 
Qom settlement at the suburbs of Resistencia City (Fisher Exact test, p= 2.e-21).The 
kDNA-PCR positivity was 42.15% in Aboriginal communities and 65.71% in Creole 
populations (Chi square, p=  5.e-4).  Among Aboriginal communities kDNA-PCR 
positivity was heterogeneous (Chi square, p= 1.e-4). Highest kDNA-PCR positivity 
(79%) was detected in the Qom community of Colonia Aborigen and the lowest PCR 
positivity in two different surveys at the Wichi community of Misión Nueva Pompeya 
(33.3% in 2010 and 20.8% in 2014). 
TcV (or TcII/V/VI) was predominant in both Aboriginal and Creole communities, in 
agreement with DTU distribution reported for the region. Besides, two subjects were 
infected with TcVI, one with TcI and four presented mixed infections of TcV plus 
TcII/VI. Most minicircle signatures clustered according to their original localities, but   
in a few cases, signatures from one locality clustered with signatures from other 
village, suggesting circulation of the same strains in the area. Parasitic loads ranged 
from undetectable to around 50 parasite equivalents/mL, showing higher values than 
those generally observed in chronic Chagas disease patients living in urban centres 
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INTRODUCTION  
Chagas’ disease represents a devastating health and social threat to around eight 
million infected people in 21 Latin American countries, and is emergent in non- 
endemic countries introduced by extensive global migrations and perpetuated by 
means of vertical transmission (Rodrigues Coura and Viñas, 2010). The infection 
mainly affects rural and neglected populations, such as Aboriginal groups, since they 
are highly exposed to the risk of vectorial transmission, as a consequence of poverty 
and lack of sanitized households. Many Creole populations resulting from 
miscegenation with European colonists and immigrants coexist within these native 
communities.  
In Argentina, the Chagas’ disease National Program has achieved important 
decreases in the rates of parasitic transmission by blood transfusion, vectorial 
pathway and prenatal care for congenital transmission, especially among non-
indigenous communities. Deficient spraying and discontinuity of surveillance favors 
persistence of highly endemic areas (Zaidenberg, 2014). Aboriginal houses are much 
more likely to be infested with Triatoma infestans than Creoles’ houses; indigenous 
people mostly tend to thatch the roofs and often sleep on the floor, providing the 
vector with a more primary habitat than just mud walls. Moreover, the lack of timely 
reporting of re-infestation opens the way for renewed transmission (Dell´ Arciprete et 
al., 2014). Besides, among indigenous groups, culture and language differences 
make control efforts more difficult (Dell´Arciprete et al., 2014). 
 
By year 2010, according to the Survey of Indigenous Population of the National 
Institute of Statistics and Census (INDEC, 2010), there were 955,032 people in 
Argentina who self-recognised and/or identified themselves as belonging to an 
indigenous community minority. At the present time, ten well-defined indigenous 
ethnias are recognized in the country, 90% of them living within “the Gran Chaco 

















Three different indigenous ethnias inhabit the province of Chaco, namely Qom, 
spanish-called Toba, that includes 30,000 individuals living in urban and rural areas 
of central and southeastern plains of the province; Wichis, spanish-called Mataco, 
that comprises approximately 6,500 individuals living in rural communities in the 
northwestern corner of the province called “Monte Impenetrable Chaqueño” and 
Moquoít, spanish-called Mocoví, that includes approximately 6,500 individuals living 
in the southwestern area of the province. Moreover, in the province of Formosa, the 
Pilagá, originally named Pit´laxá, are nowadays situated in 19 settlements. 
Indigenous populations mostly live in rural locations with severe housing constrictions 
and with limited access to health care services. In many locations there are no 
medical facilities within or close to the settlements and there is also lack of medical 
staff trained to understand their cultural characteristics and languages (Petherick, 
2010).  
Currently, T. cruzi is partitioned into six discrete typing units (DTUs) renamed by 
consensus as TcI–TcVI (Zingales et al., 2009, 2012). Epidemiologically relevant T. 
cruzi DTUs and genetic parasite diversity infecting native populations remain to be 
determined. Most DTU typing methods have used DNA from cultured parasites, 
which may underestimate the diversity of natural populations due to subpopulation 
selection during culturing procedures (Diosque et al., 2003; Macedo et al., 2004). 
Moreover, parasite cultures from blood samples of chronically infected cases have 
very low sensitivity. In the last years, sensitive PCR strategies have been developed 
for typing of T. cruzi in clinical samples (Burgos et al., 2007, 2010; Zingales et al., 
2012; Monje-Rumi et al., 2015; Cura et al., 2015). This has opened the possibility to 
deepening our understanding of parasite genetic diversity in native communities.  
In this context, this work aimed to characterize serological and parasitological 
features of affected Aboriginal and Creole communities residing in rural neglected 
areas of the Argentinean Gran Chaco. 
 
Materials and Methods 
 

















Between August 2010 and March 2014, T. cruzi infection was searched in a total of 
861 individuals inhabiting the Provinces of Chaco and Formosa, in the argentinean 
Gran Chaco Region. A total of 604 out of 861 individuals belonged to eight Aboriginal 
communities at a) Province of Chaco: seven rural villages of Colonia Aborigen, N= 35 
and Las Hacheras, N= 60 (ethnia Qom); Miraflores, N= 46 (ethnias Wichi and Qom); 
Misión Nueva Pompeya survey 2010, N= 55 Misión Nueva Pompeya survey 2014, 
N= 110 (ethnia Wichi, different individuals studied in each survey) and Villa Berthet, 
N= 115 (ethnia Mocoit) and the urban Mapic settlement in the suburbs of Resistencia 
city, known as “Gran Resistencia”,  N= 108 (ethnia Qom) and  b) Province of 
Formosa: rural communities of Estanislao del Campo, N= 53 ( ethnia Pit´laxá) and El 
Potrillo, N= 22 (ethnia Qom) (Figure 1 and Table 1). 
Furthermore, 257 out of 861 individuals belonged to Creole rural populations of the 
Province of Chaco: Concepción del Bermejo (N= 49), Las Breñas (N= 67), Las 
Garcitas (N= 54) and Lapachito (N=87) (Figure 1 and Table 1). 
The study was approved by the bioethical Committee of The Institute of Regional 
Medicine of the Northeastern National University (UNNE), Resistencia, Chaco and 
IDACH (Chaco Aboriginal Institute) upon written informed consents of adult 
individuals or parents/tutors in pediatric cases. 
 
Serological examination  
Conventional serological tests were assayed in the Immunological Department of the 
Institute of Regional Medicine or in the Parasitology School of the Faculty of 
Biochemistry of the UNNE. Indirect hemagglutination (Chagatest® Wiener Lab, 
Argentina; cut-off 1:32) and Ig G-ELISA test (ELISA Chagatest®, Wiener Lab, 
Argentina) were performed following the manufacturers´ instructions. In case of 
discordant findings, a third serological test was carried out using indirect 
immunofluorescence (Biocientífica, Argentina), following the manufacturers´ 
instructions. Subjects were considered infected if at least two tests were positive.  
Seropositive individuals were notified to the Provincial Public health Chagas 
program, in coordination with the Health Care program of the UNNE (UNNE-SALUD), 

















following the normative in Argentina.  However, these data were not available for the 
present study. Digestive megasyndromes were not studied.  
 
PCR detection of bloodstream T. cruzi DNA. 
PCR based detection of the 330-bp minicircle variable region of parasitic 
kinetoplastid DNA (kDNA-PCR) was carried out in blood samples of seropositive 
subjects using primers 121 and 122, as reported (Schijman et al., 2011). Seven 
hundred µL of peripheral blood were collected in EDTA tubes and stored at -20C 
until DNA extraction. The DNA was purified with CTAB (Hexadecyltrimethyl 
Ammonium Bromide) as previously reported (Escalante, 1997; Lucero, 2007).  
Quantification of parasitic loads using TaqMan Real Time PCR (qPCR). 
Parasitic loads were determined in a group of kDNA-PCR positive samples by means 
of TaqMan Real Time PCR (qPCR) targeted to a 166-bp segment from T. cruzi 
satellite DNA (SatDNA) using FastStart Universal Probe Master Mix (Roche 
Diagnostics GmbHCorp, Mannheim, Germany) in a final volume of 20 µL and the 
following reagents: 0.75 µM of primers Cruzi 1 (5’-ASTCGGCTGATCGTTTTCGA-3’) 
and Cruzi 2 (5’AATTCCTCCAAGCAGCGGATA-3’), and 0.05 µM of specific TaqMan 
probe Cruzi 3 (5’-Fam-CACACACTGGACACCAA-NFQ-MGB-3’). Thermocycling 
conditions were a first step of 10 min. at 95ºC followed by 40 cycles at 95ºC for 15 
sec. and 58ºC for 1 min. (Ramirez J.C. et al., 2015). 
For quantification, a standard curve was prepared from DNA obtained using CTAB 
reagent from a seronegative blood sample spiked with 105 CL Brener parasites/mL. 
The DNA was mixed with DNA obtained by the same way from a seronegative blood 
sample in order to create a series of dilutions ranging from 0.1 to 104 parasite 
equivalents in 1 mL of blood (par.eq/mL).  
 
Analytical Validation of DNA extraction and PCR.  
DNA extraction with CTAB was validated for conventional PCR using external control 
panels provided by a referral Laboratory of Molecular Diagnosis at INGEBI-CONICET 
in the context of an International PCR harmonization study (See LbP/2 in Tables 1 

















To validate Sat DNA-qPCR serial dilutions of seronegative EDTA-blood spiked with 
0.05 to 105 par.eq./mL of cultured CL Brener were constructed. An anticipated linear 
reportable range (Burd, 2010) was obtained between 0.125 and 105 par.eq./mL 
(Correlation coefficient (r2) 0.99, Efficiency 1.05).  
The integrity of DNA purified with CTAB was evaluated by means of a qPCR targeted 
to the RNAse P human single copy gene (TaqMan Human RNase P detection 
reagent, Applied Biosystems, USA) and the resulting Cts were compared to those 
obtained from GEB samples extracted by a commercial column, considering that 
Cts≤ 22 indicate adequate integrity of DNA (Ramirez et al., 2015). The RNAse P-
PCR cycling conditions involved a first step of 10 min at 95°C followed by 40 cycles 
at 95°C for 15 sec and 58°C for 1 min. The DNA was obtained using the CTAB 
reagent in exactly the same way as described for spiked and clinical samples.  
To validate Sat-DNA qPCR for measurement of parasitic loads, we carried out a 
recovery study to measure “Trueness” of the assay (Burd, 2010) using proficiency 
testing samples and compared results from the method under evaluation to the 
expected reference value. The proficiency samples were constituted by a blinded 
panel of seronegative EDTA-blood samples spiked with known quantities of Cl 
Brener, as follows: panel A: three samples containing 1 par.eq/mL; panel B: three 
samples containing 10 par.eq/ml and panel C: three samples containing 100 
par.eq/mL. The panels are similar to the ones used in recent clinical trials with anti-
parasitic drugs (Molina et al, 2015). Testing was spread over 2 independent runs, 
separated by a period of two months using the same reagent lots, as recommended 
(Burd, 2010).  
 
Genotyping of discrete typing units. 
Parasite DTUs were determined in kDNA-PCR positive DNA samples, using a PCR 
algorithm targeted to parasite nuclear genes, as described in Burgos et al., 2007. 
Briefly, (1) spliced leader intergenic region (SL-IR) based PCR was used to 
distinguish TcI (150 bp), TcII, TcV, and TcVI (157 bp) from TcIII and TcIV (200 bp); 
(2) heminested SL-IR-I PCR was used to identify TcI (350 bp), and hemi-nested SL-
IR-II PCR was used to identify TcII, TcV, and TcVI (300 bp); (3) hemi-nested PCR of 
the 24S alpha-ribosomal DNA (24 Sα-rDNA) was used to distinguish TcV (125 or 

















targeted to genomic fragment A10 was used to discriminate TcII (580 bp) from TcVI 
(525 bp).  
Analytical sensitivity of each PCR assay is detailed elsewhere (Burgos et al., 2007). 
Samples that yielded positive results by SL-IR-II PCR but negative by 24S α-rDNA 
PCR were reported as belonging to the TcII/V/VI group. Those samples that 
amplified the 140-bp 24S α-rDNA fragment but had negative results of PCR targeted 
to A10 were reported as belonging to the TcII/VI group. Those samples amplifying a 
band of 125 bp plus a strong 140 bp fragment after 24S α-rDNA PCR, were 
interpreted as mixed infections by TcV plus TcII or TcVI, as done before (Burgos et 
al., 2007).  
 
Minicircle signatures. 
Genetic diversity of natural T.cruzi populations was explored by Low stringency 
single primer PCR (LSSP-PCR) (Vago et al., 1996) of the 330 bp amplicons from a 
group of kDNA-PCR positive samples obtained from Aboriginal patients inhabiting 
the localities of “Monte Impenetrable Chaqueño”. Ten L of the kDNA-PCR products 
were run on 1.5% low melting point agarose gels and stained with ethidium bromide. 
Bands corresponding to 330 bp were cut from the gel, melted and diluted to 1:10 in 
double distilled water. Three L of the dilution was used as a template for the LSSP-
PCR reaction. LSSP-PCR was performed in 20µL of the final volumen using 150 
pmol of the S35 primer, 5U/µL of GoTaq® DNA polymerase (Promega), 2.5 mM of 
each dNTP, 25mM of MgCl2 and buffer 10X. Amplification was carried out with 5 min 
of initial denaturing at 94ºC, followed by 40 cycles of 30ºC for 1 min, 72ºC for 1min 
and 94ºC for 1 min. Finally 30ºC for 1 min and a cycle at 72ºC for 10 min. Five L of 
the amplification products were analysed by electrophoresis in 6% polyacrylamide 
gels and stained with Sybr Green. LSSP-PCR was performed on duplicate for each 
sample.  
Analysis of the bands was performed using Gel documentation and analysis systems 
(Uvitec. Cambridge, UK). Molecular weight markers were used as reference 
standards to correct the variations in migration among the different gels. The 
fragment sizes were calculated using UVIsoft analysis software. A data matrix of 0 
and 1 was created on basis of the absence or presence of the bands, respectively. 

















FreeTree(http://web.natur.cuni.cz/ ~flegr/programs/freetree.htm). The dendrogram 





Categorical variables were compared using the χ2 test or the Fisher Exact test. 
Mann-Whitney test was used for non-parametric analyses.  Comparison of 
distribution of parasitic loads among populations was done using Anova, once 
similarity of variances was demonstrated using the Levene´s test.  
P values < 0.05 were considered as significant. 
 
RESULTS 
Seroprevalence in Aboriginal and Creole populations. 
Eight aboriginal communities were studied; seven reside in rural villages at the 
Provinces of Chaco and Formosa (496 individuals, Wichi, Pit´laxá, Mocoit and Qom) 
and one in the urban Mapic settlement of the suburbs of Resistencia city, known as 
“Gran Resistencia” (108 individuals, Qom) (Figure 1 and Table 1). Furthermore, four 
rural villages inhabited by Creole populations were included (257 individuals). 
Detection of seropositivity for T. cruzi allowed diagnosis of Chagas disease in 238 
out of 496 rural boriginal (47.98%) and in 70 out of 257 Creole tested subjects 
(27.23%) (Chi square test, p = 4.e-8).  A higher seroprevalence was detected in those 
localities sited more distant from urban centres, such as Colonia Aborigen (51.4%), 
Las Hacheras (56.7%), Miraflores (52.2%) and Misión Nueva Pompeya (survey in 
2010, 54.5% and survey in 2014, 43.64%) (Table 1). In contrast, the urban Qom 
community of Mapic settlement presented a seroprevalence of 4.3%, significantly 
lower than that found in rural Aboriginal villages (Fisher Exact test, p= 2.e-21) (Table 
1).  
 

















Molecular studies of T. cruzi infection were carried out from 700 µL of frozen EDTA-
blood samples using CTAB reagent for DNA extraction (see Materials and Methods). 
The integrity of DNA extracted by CTAB was evaluated by means of a qPCR assay 
targeted to the RNAse P human single copy gene in 44 samples from three 
communities. Median Cts (Q1-Q3) obtained from samples of the different 
communities were similar: 18.24 (17.66-19.77); 18.91 (18-19.83) and 19.4 (18.55-
21.26) in samples from Las Hacheras, Miraflores and Misión Nueva Pompeya 
(survey 2010), respectively (Mann-Whitney tests, p= ns). These Ct values indicated 
that the DNA quality was adequate for T. cruzi based PCR analyses (Materials and 
Methods). Then, blood samples from seropositive patients were tested for the 
presence of parasite DNA using conventional kDNA-PCR (Table 1). Overall kDNA-
PCR positivity was 42.15% in Aboriginal communities and 65.71% in Creole 
populations (Chi- square test, p = 5.e-4). Among Creole communities there was no 
significant difference in PCR positivity (Chi-square test, p = 0.690) whereas among 
Aboriginal communities there was (Chi square test, p = 1.e-4). The highest kDNA-
PCR positivity (79%) was detected in the Qom community of Colonia Aborigen and 
the lowest PCR positivities were observed in samples from the Wichi communities of 
El Potrillo (2/6 seropositives) and Misión Nueva Pompeya (survey in 2010 (10/30 
seropositives, 33.3%) and survey in 2014 (10/48 seropositives, 20.8%), (Table 1).  
In 54 kDNA-PCR positive patients from three rural communities of Monte 
Impenetrable, parasitic loads were measured using qPCR (Figure 2 and Table S1). 
There were no significant differences in the mean parasitic loads among the tested 
communities:  Miraflores: 4.48 par.eq/mL; Las Hacheras: 2.48 par.eq/mL; Misión 
Nueva Pompeya: survey in 2010, 1.45 par.eq/mL and in 2014, 4.44 par.eq/mL 
(Anova test, p = 0.745; Levene´s test, p = 0.716). The trueness of the obtained 
values was assessed using blinded panels of seronegative blood spiked with CL 
Brener parasites spanning concentrations in the range of 1 to 100 par.eq/mL (see 
Materials and Methods). The linear regression analysis gave a correlation coefficient 
(r2) of 0.9612, which indicated good correlation between expected and observed 
parasitic loads (Figure 2). 
Discrete typing units and minicircle signatures:  
A total of 127 kDNA-PCR positive blood samples, 92 from Aboriginal and 35 from 

















genomic markers, as detailed in Materials and Methods. The DTUs could be 
determined in 76/92 and 27/35 samples from Aboriginal and Creole populations, 
respectively. TcV and TcII/V/VI were detected in 43/76 and 30/76 samples from 
Aboriginal and in 10/27 and 13/27 samples from Creole patients, respectively. Two 
samples, one from Las Hacheras and one from Las Garcitas were infected with TcVI. 
In four samples, one from Las Hacheras, one from Miraflores, one from Las Breñas 
and one from Lapachito, the amplification of two strong amplicons of 125 bp plus 140 
bp using 24Sα-rDNA-based PCR were compatible with mixed infections by at least 
two DTUs: TcV plus TcII or TcVI (V + II/VI in Table 1). Finally, a single sample from a 
Creole patient of Las Breñas was infected with TcI. TcIII and TcIV were not detected 
in the studied population.  
Minicircle signatures were obtained by LSSP-PCR from the 330bp kDNA-PCR 
products of blood samples infected with TcV or Tc II/V/VI from aboriginal patients of 
Las Hacheras, Miraflores and Misión Nueva Pompeya (survey 2010). Specific LSSP-
PCR patterns were observed in each community. Figure 3A shows examples of  
minicircle signatures obtained after gel electrophoresis; diversity in size and number 
of LSSP amplicons was observed among most samples from the same village (eg 
lanes 1 to 3 and 11 to 14 from Miraflores,  lanes 17 to lane 24 from Misión Nueva 
Pompeya (survey in 2010); lanes 25 to 28 from Las Hacheras). Some parasite 
populations typed from patients´ samples of different communities presented similar 
signatures (eg. Lane 1, M4 from Miraflores and Lane 8, LH231 from Las Hacheras) 
suggesting circulation of the same populations, which can be explained due to their 
geographical proximity. This can be observed in the dendrogram of Figure 3B, which 
shows clusters grouping the majority of samples from each locality except single 
samples that group in clusters from the neighbouring villages, suggesting circulation 
of the same strains (Figure 3B, red circles). 
 
Discussion 
Despite significant gains in the reduction of Chagas disease burden in many endemic 
countries, active transmission remains in areas such as the Gran Chaco. High initial 

















and a lack of systematic insecticide spraying and vector surveillance have previously 
been incriminated for failure to interrupt and sustain interruption of transmission.  
We have studied Aboriginal communities that inhabit highly endemic areas for 
Chagas disease, such as the Monte Impenetrable Chaqueño, and observed high 
seroprevalences, similar to those reported a decade before: 57% in Chaco and 48% 
in Formosa (Biancardi et al., 2003; Alonso et al., 2004). An exception was the low 
seroprevalence found in the Qom community at Mapic settlement located in the 
surroundings of Resistencia city (4.3%, Table 1), which may be explained because 
all houses in the settlement have plastered-brick walls with metallic roofs. Previous 
studies showed that the prevalence of domestic infestation was lower in well 
plastered houses than in dwellings with walls with cracks. Thus, plastering of walls 
would be cost-effective in the long-term sustainability of vector control because such 
houses would be less susceptible to triatomine re-colonization (Gürtler, 2009).  
Studies by Moretti and coworkers carried out in Wichi and Creole communities from 
Misión Nueva Pompeya and surrounding rural villages showed very high 
seroprevalences too (Moretti et al., 2010), more than 10 times higher than the 
average for Argentina reported by Moncayo and Silveira (2009).  
Cultural and educational aspects may account for the impact of T. cruzi infection in 
native populations. Dell´Arciprete and coauthors described that neither the Pit´laxá or 
Wichi communities perceive the triatomine vector, known as “vinchuca”, as a health 
risk and this perception has consequences on their attitudes with regards to vector 
surveillance and control. Indeed, household education is considered a generic 
measure of household socioeconomic status, which is among the main social 
determinants of health inequalities (WHO, 2010).  
In Creole villages, higher seroprevalences were found in Las Garcitas and Las 
Breñas, although they did not reach the proportions found in most Aboriginal 
communities. In Concepción del Bermejo, seroprevalence was lower, probably due to  
succesful vector control achieved in that locality, thanks to a special surveillance 
program launched by a public-private parternship (http://asp-es.secure-
zone.net/v2/index.jsp?id=8177/13194/28297&lng=es). 
Gürtler (2009) showed that the household seropositivity to T. cruzi in rural villages of 

















domestic area,  a putative index of stable settlement and well-being in Creole 
communities of the dry Chaco (Gürtler, 2009). A recent sociodemographic study in 
Pampa del Indio, in the province of Chaco revealed that Qom households likely were 
more infested than Creoles because of the convergence of multiple factors closely 
related to structural rural poverty, such as poor housing quality, residential 
overcrowding, less frequent insecticide use, rather than to direct ethnic or cultural 
effects facilitating house invasion and colonization by triatomine bugs. After 
accounting for the effects of other factors with high relative importance, ethnicity per 
se was a poor predictor of house infestation status (Gaspe et al., 2015).  
 
Seroprevalence studies have been done in indigenous populations from other 
endemic countries.  Samuels and coauthors showed an overall T. cruzi 
seroprevalence of 51.7% in areas of the Bolivian Chaco, that reached 97.1% among 
participants older than 30 years. In that study, sleeping in a structure with cracks in 
the walls was associated with infection (Samuels et al., 2012). Chico and coauthors 
studied 18 sylvatic communities along the Río Napo in Ecuador and found infection 
in 15 communities, with seroprevalences reaching 18.8% in adults 50 years or older 
(Chico et al., 1997). Many factors, such as diversity of T. cruzi strains circulating in 
different endemic areas, the use of different parasite antigens in the serological 
assays tested in each region and diverse susceptibility to infection of different 
ethnias, might account for these geographical variabilities (Porrás et al., 2015). 
According to WHO, development of new methods for diagnosis of infection is one of 
the ten top priorities in Chagas disease research (WHO, 2015). The CTAB based 
DNA extraction method that starts from a small volume of frozen EDTA-blood has 
been appropriate for conventional kDNA-PCR, qPCR for quantification of parasitic 
loads as well as for direct DTU genotyping. The human RNase P gene based qPCR 
yield was higher than that obtained in DNA extracts using fiber-glass columns from 
300 L of an initial 10 mL GEB sample (median Ct=21.40, Q1=20.55, Q3=22.68; 
Ramirez, J.C. et al., 2015).Thus, the method appears suitable for PCR laboratories 
close to endemic localities, where samples can be collected in EDTA tubes and 
transported within a few hours to the Molecular Biology facility and stored frozen until 

















extraction and that interacts with substances than could inhibit the PCR (Escalante et 
al., 1997). 
Overall kDNA-PCR positivity in Creole communities (65.71%) was in agreement with 
values obtained in other studies of chronic Chagas disease patients (Schijman et al., 
2011). In an International study organized by WHO-TDR, the kDNA-based PCR tests 
with best performance in terms of accuracy gave 63% of positivity in a panel of 
chronic Chagas disease samples (Schijman et al., 2011) and in the BENEFIT study , 
kDNA-PCR performed in 1896 chronic Chagas disease patients rendered a positivity 
of  60.5% at baseline (Morillo et al, 2015).  
The kDNA-PCR positivity detected in the Qom community of Colonia Aborigen was 
higher (79%), but eight of the 15 PCR positive subjects were children. It has been 
shown that most children harbor higher levels of parasitemia than adults (Burgos et 
al., 2007; Duffy et al., 2009; Bua et al., 2013).  
It is remarkable the low kDNA-PCR positivity obtained in the Wichi population of 
Misión Nueva Pompeya (Table 1). The fact that similar PCR positivity was obtained 
from samples collected in two surveys separated by a period of four years, suggests 
a particular characteristic of these populations rather than technical problems in the 
collection, transportation and/or processing of samples in the PCR laboratory. 
Moreover, the RNAse P PCR based analysis in samples from this community gave 
similar Ct values than those obtained in Miraflores and Las Hacheras, where the 
DNA-PCR positivities were higher (Table 1). It is tempting to speculate that host 
factors could play a role in the control of parasite infection, virulence and/or tropism. 
Characterization of human genetic polymorphism to elucidate its association with 
infection susceptibility and clinical manifestations has been recently done in other 
populations infected with T. cruzi (Juiz et al., 2015; De Oliveira et al., 2015) and is 
currently undergone in patients of the ethnia Wichi from this locality (Juiz Natalia and 
Gonzales, Clara Isabel, personal communications).To our knowledge, this is the first 
study evaluating parasitic loads in Aboriginal populations. Parasitic loads were 
estimated from kDNA-PCR positive DNA extracts using a validated qPCR method 
targeted to satellite DNA (Duffy et al., 2013; Ramirez J.C. et al.; 2015). Similar 
distribution of parasitic loads was seen in Miraflores, Las Hacheras and in both 

















pre-treated patients residing in non-endemic urban areas from Argentina displayed a 
median parasitemia of 2.1 (1.18 to 2.78) par.eq/ml using a similar qPCR test (Alvarez 
et al., 2015) and in argentinean patients admitted to the BENEFIT study, a median 
parasitemia of 1.93 par. eq/mL was obtained using the same pair of primers in a 
SYBRGreen Real-Time PCR approach (Moreira et al., 2013). In our study, in Monte 
Impenetrable, some patients presented higher parasitic loads than those expected 
for chronic patients, between 10 and 52 par.eq/mL (Table S1). It is tempting to 
speculate that in chronic Chagas disease patients from these rural areas, higher 
kDNA-PCR positivity and parasitic loads could indicate the occurrence of events of 
re-infection. In fact, in Miraflores, microscopic analysis of feces from 512 T. infestans 
bugs collected in 2012 showed that 65% of them were infected with T. cruzi 
(Fernández Gustavo, unpublished results), pointing to a high risk of vectorial 
transmission in that village. Longitudinal studies of parasitic loads in sequential 
samples from patients living in rural endemic areas would allow deepen insight in the 
natural fluctuations of parasitic burden in populations exposed to the risk of re-
infection.  
There is very scarce information regarding the distribution of DTUs in areas inhabited 
by Aboriginal communities. In two rural areas of the Argentinean Gran Chaco human 
blood samples typified by PCR-DNA blotting and hybridization assays with specific 
DNA probes showed TcV as the most prevalent DTU (30.6%) followed by mixed 
infections TcV/TcVI (32.6%), (Monje-Rumi et al., 2015). In the Bolivian Chaco, 
studies in triatomine bugs revealed predominance of TcII/TcV/TcVI followed by TcI, 
TcIII/TcIV and mixed infections (Perez et al., 2013). Thus, the prevalence of TcV or 
TcII/V/VI   in our setting is in accordance with the above mentioned reports and with 
other ones carried out previously from cultured isolates in the Gran Chaco Region 
(Diosque et al., 2003; Cardinal et al., 2008). In contrast to the work by Monje-Rumi et 
al. ( 2015) we detected only two patients infected by TcVI and four mixed infections 
of TcV/TcVI or TcII (Table 1). The use of different molecular typing approaches may 
account for these differences, which make necessary to reach a consensus for 
standardization and validation of techniques for molecular genotyping of T. cruzi, 
such as it has been done with respect to conventional and quantitative PCR for 
monitoring Chagas disease patients under treatment (Schijman et al., 2011; Ramirez 

















A single sample with TcI was detected, out of 12 typed samples in the Creole village 
of Las Breñas. TcI had been identified before in patients from the Gran Chaco region 
(Diosque et al., 2003; Cura et al., 2012). In addition, studies in chronic patients from 
Chaco who underwent Chagas reactivation due to heart transplantation, allowed 
identification of TcI strains that were detectable only after immunosuppressive 
therapy, whereas samples taken from these patients before transplantation were 
kDNA-PCR negative (Burgos et al., 2010). This may suggest that TcI strains from 
this region might circulate at very low parasitic loads and thus their detection is 
infrequent. It could be hypothesized that TcI and perhaps other DTUs could circulate 
in seropositive patients with very low parasitic loads, such as in those showing 
positive kDNA-PCR but negative SL-IR and/or 24Sα-rDNA PCR results and in those 
with negative kDNA-PCR findings. This, in turn could be related to the tissue tropism 
of TcI strains (Burgos et al., 2010). 
Minicircle signatures obtained by LSSP-PCR of T. cruzi sequences amplified from 
infected tissues has been proposed as a useful tool to study the molecular 
epidemiology of Chagas' disease (Vago et al., 1996; Macedo et al., 2004). We 
carried out LSSP-PCR from kDNA amplicons obtained in samples infected with the 
predominant DTU, typed as TcV or TcII/V/VI, and observed infra-DTU diversity that 
was associated with the geographical origin. Moreover, in Miraflores, LSSP-PCR was 
done in parasite populations obtained from three infected triatomine bugs (Mv1 to 
Mv3) collected in a domicile (lanes 4, 5 and 7 in Figure 3A) that clustered with 
signatures from patients of the same locality (Figure 3A; M17, lane 3; M40, lane 4; 
Mv1 to Mv3, lanes 5, 6 and 8, respectively). Interestingly, minicircle signatures from 
parasite populations infecting bugs presented a higher number of fragments than 
those from human subjects at the same locality, probably representative of a higher 
degree of diversity (Figure 3). This was also observed using polymorphic 
microsatellites (Oliveira et al., 1998), suggesting that subpopulation selection occurs 
in the human host (Macedo et al., 2004). 
In a report of the Panamerican Health Association (PAHO, 2008), the Gran Chaco 
Americano is characterized as a setting in which the impact of control measures for 
infestation is minimized by its eco-epidemiological characteristics. Its enormous 
extension and inaccessibility and the low density of population make any operational 

















attention regarding surveillance and control procedures, considering the whole region 
as an epidemiological unit and not as national areas with political-administrative 
boundaries. Indeed, these findings reveal a serious situation with high rates of 
infection and persistent transmission in native populations. 
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Legend to Figures 
 
Figure 1  
Map showing the Aboriginal and Creole groups in the Provinces of Chaco and 
Formosa. The localities under study are indicated. 
 
Figure 2. 
Parasitic loads measured by qPCR targeted to Satellite DNA  (TaqMan Real Time 
PCR) in three populations of Monte Impenetrable Chaqueño, including two surveys in 
Misión Nueva Pompeya ( different patients) and in external control panels. Panel A: 
six spiked blood samples containing 1 par.eq/mL; panel B: six spiked blood samples 
containing 10 par.eq/ml and panel C: six spiked blood samples 



















Minicircle signatures from natural T.cruzi populations infecting aboriginal populations 
of Northeastern Argentina.  
A: Minicircle signatures obtained by LSSP-PCR from bloodstream TcV parasite 
populations from Miraflores (Mn); Misión Nueva Pompeya (MNPn) and Las Hacheras 
(LHn). Lanes: 1, M4; 2, M17; 3, M40; 4, Mv1; 5, Mv2; 6, MW marker; 7, Mv3; 8, 
LH231; 9, LH232; 10, LH culture isolate; 11, M43; 12, M107; 13, M58; 14, M49; 15, 
MW marker; 16, M47; 17, MNP255; 18, MNP262; 19, MNP265; 20, MNP266; 21 MW 
marker; 22, MNP270; 23, MNP283; 24, MNP287; 25, LH200; 26, LH201; 27, LH210; 
28, LH211; 29, MW marker. Mv1 to 3 represent parasitic populations from three 
triatomine fecal samples collected from a house in Miraflores. 
B: Dendrogram from LSSP-PCR based signatures shown in A. Bootstraps are 
indicated in the nodes and red circles show minicircle signatures from samples of a 
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TABLE 1.  Serological, kDNA-PCR and DTU findings in Aboriginal  and Creole communities from 
Northeastern Argentina. 
Locality / ethnia 







N       (% ) 
kDNA -PCR  
positive cases 
N        (%) 
Number of DTU 
 typed / 
 kDNA- PCR +  
DTU (N) 
 















Media : 24 
SD 15.54 
6 (27.3) 2(33 ) 2/2 V (2) 



















19 (54.3) 15 (79) 
 

































34 (56.7) 22 (64.7) 
 
16/22 V (6) 
VI (1) 
II/V/VI (8) 
V+ II/VI (1) 
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Median 28  
Media 31.0 
SD 13.3 






































10 (11.49) 5 (50) 4/5 V (1) 
II/V/VI (2) 










31 (46) 21 (68) 12/16 V (5) 
II/V/VI (5) 































El Potrillo: 27.3% seropositives, 33% kDNA PCR positives, DTU: V 
Estanislao del Campo: 47.2% seropositives, 36% kDNA PCR positives, DTU: II/V/VI 
Nva. Pompeya 2010: 54.5% seropositives, 33.3% kDNA PCR positives, DTU: V; II/V/VI 
Nva. Pompeya 2014: 43.6% seropositives, 20.83% kDNA PCR positives , DTU: ND 
Las Hacheras: 56.7% seropositives, 64.7% kDNA PCR positives, 
DTU: V;VI; II/V/VI; V+II/VI 
Miraflores: 52.2% seropositives, 58.3% kDNA PCR positives, 
DTU: V;II/V/VI; V+II/VI 
C. Aborigen: 54.3% seropositives, 79% kDNA PCR positives, 
DTU: V; II/V/VI 
Mapic: 3.7% seropositives, 50% kDNA PCR positives, 
DTU: V;II/V/VI 
V. Berthet: 45.2% seropositives, 34.6% kDNA PCR positives, 
DTU: V; II/V/VI 
Lapachito: 11.49% seropositives, 50% kDNA PCR positives, 
DTU: V; II/V/VI; V+II/VI 
Las Garcitas: 38.9% seropositives, 66.6% kDNA PCR positives, 
DTU: V; II/V/VI;VI 
Las Breñas: 46% seropositives, 68% kDNA PCR 
positives, DTU: V; II/V/VI;V+II/VI; I 
C. del Bermejo: 16.32% seropositives, 




Seropositivity > 50% 
Seropositivity 30- 50% 
Seropositivity 10- 30% 



















 Infection by Trypanosoma cruzi was searched in Qom, Mocoit, Pit´laxá and 
Wichi ethnias and Creole communities inhabiting rural villages from two highly 
endemic provinces of the Argentinean Gran Chaco. 
 Seroprevalence was high in Aboriginal and Creole rural communities. Low 
seroprevalence was detected in a urban Qom settlement in the region.  
 PCR targeted to minicircle sequences show high variability in PCR positivity 
among different Aboriginal communities. 
 Parasitic loads showed similar distribution in rural villages of the Monte 
Impenetrable Chaqueño, and revealed cases with higher parasitemias than 
those expected for argentinean chronic Chagas disease patients of urban 
centers, suggesting the occurrence of re-infections.  
 Discrete typing units were identified directly from blood samples showing TcV 
as the predominant DTU followed by TcVI, TcI and mixed infections.  
